Key Benefits
Nudoxa 50Mg/ 25Ml Inj contains Doxorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis. Nudoxa 50Mg/ 25Ml Inj is also used in the treatment of acute lymphoblastic leukaemia, acute myeloblastic leukaemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms’ tumour, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, metastatic bronchogenic carcinoma
Directions for Use
Side Effects
-
Nausea
-
Abdominal pain
-
Vomiting
-
Dizziness
-
Back pain
-
Pain at the site of injection
-
Red discolouration of urine
-
Loss of appetite
-
Mouth sores
-
Tiredness
-
Weight gain